Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of copper transporters in platinum resistance.

Literature DB >> 26862494

Role of copper transporters in platinum resistance.

Deepak Kilari¹, Elizabeth Guancial¹, Eric S Kim¹.

Abstract

Platinum (Pt)-based antitumor agents are effective in the treatment of many solid malignancies. However, their efficacy is limited by toxicity and drug resistance. Reduced intracellular Pt accumulation has been consistently shown to correlate with resistance in tumors. Proteins involved in copper homeostasis have been identified as Pt transporters. In particular, copper transporter receptor 1 (CTR1), the major copper influx transporter, has been shown to play a significant role in Pt resistance. Clinical studies demonstrated that expression of CTR1 correlated with intratumoral Pt concentration and outcomes following Pt-based therapy. Other CTRs such as CTR2, ATP7A and ATP7B, may also play a role in Pt resistance. Recent clinical studies attempting to modulate CTR1 to overcome Pt resistance may provide novel strategies. This review discusses the role of CTR1 as a potential predictive biomarker of Pt sensitivity and a therapeutic target for overcoming Pt resistance.

Entities: Chemical Disease Gene

Keywords: ATP7A; ATP7B; Cisplatin; Copper transporter; Copper transporter receptor 1; Copper transporter receptor 2; Resistance

Year: 2016 PMID： 26862494 PMCID： PMC4734932 DOI： 10.5306/wjco.v7.i1.106

Source DB: PubMed Journal: World J Clin Oncol ISSN： 2218-4333

83 in total

1. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase.

Authors: T D Rae; P J Schmidt; R A Pufahl; V C Culotta; T V O'Halloran
Journal: Science Date: 1999-04-30 Impact factor: 47.728

Review 2. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.

Authors: Matthew D Hall; Mitsunori Okabe; Ding-Wu Shen; Xing-Jie Liang; Michael M Gottesman
Journal: Annu Rev Pharmacol Toxicol Date: 2008 Impact factor: 13.820

3. Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator.

Authors: Seiko Ishida; Frank McCormick; Karen Smith-McCune; Douglas Hanahan
Journal: Cancer Cell Date: 2010-06-15 Impact factor: 31.743

4. A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells.

Authors: Kristin D Ivy; Jack H Kaplan
Journal: Mol Pharmacol Date: 2013-03-29 Impact factor: 4.436

5. Tissue platinum concentration and tumor response in non-small-cell lung cancer.

Authors: Eric S Kim; J Jack Lee; Guangan He; Chi-Wan Chow; Junya Fujimoto; Neda Kalhor; Stephen G Swisher; Ignacio I Wistuba; David J Stewart; Zahid H Siddik
Journal: J Clin Oncol Date: 2012-08-13 Impact factor: 44.544

6. Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy.

Authors: Helen H W Chen; Jiang-Jou Yan; Wen-Chung Chen; Macus Tien Kuo; Yu-Hsuan Lai; Wu-Wei Lai; Hsiao-Sheng Liu; Wu-Chou Su
Journal: Lung Cancer Date: 2011-07-23 Impact factor: 5.705

7. Specificity protein 1 (sp1) oscillation is involved in copper homeostasis maintenance by regulating human high-affinity copper transporter 1 expression.

Authors: Zheng D Liang; Wen-Bin Tsai; Mei-Yi Lee; Niramol Savaraj; Macus Tien Kuo
Journal: Mol Pharmacol Date: 2011-12-15 Impact factor: 4.436

8. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.

Authors: Goli Samimi; Roohangiz Safaei; Kuniyuki Katano; Alison K Holzer; Myriam Rochdi; Mika Tomioka; Murray Goodman; Stephen B Howell
Journal: Clin Cancer Res Date: 2004-07-15 Impact factor: 12.531

9. Interaction of cisplatin and analogues with a Met-rich protein site.

Authors: Chak Ming Sze; George N Khairallah; Zhiguang Xiao; Paul S Donnelly; Richard A J O'Hair; Anthony G Wedd
Journal: J Biol Inorg Chem Date: 2008-11-26 Impact factor: 3.358

10. Three-dimensional structure of the human copper transporter hCTR1.

Authors: Christopher J De Feo; Stephen G Aller; Gnana S Siluvai; Ninian J Blackburn; Vinzenz M Unger
Journal: Proc Natl Acad Sci U S A Date: 2009-02-24 Impact factor: 11.205

34 in total

1. Delineation of proapoptotic signaling of anthracene-shelled M₂L₄ metallacapsules and their synergistic activity with curcumin in cisplatin-sensitive and resistant tumor cell lines.

Authors: Rositsa Mihaylova; Anife Ahmedova; Denitsa Momekova; Georgi Momekov; Nikolay Danchev
Journal: Invest New Drugs Date: 2019-02-08 Impact factor: 3.850

2. Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh.

Authors: Most Umme Bushra; Sanzana Fareen Rivu; Ali Ehsan Sifat; Noor Ahmed Nahid; Maizbha Uddin Ahmed; Mir Md Abdullah Al-Mamun; Mohd Nazmul Hasan Apu; Md Siddiqul Islam; Md Reazul Islam; Mohammad Safiqul Islam; Abul Hasnat
Journal: Mol Biol Rep Date: 2020-09-03 Impact factor: 2.316

3. Allantoin reduces cell death induced by cisplatin: possible implications for tumor lysis syndrome management.

Authors: Janaina Fernandes; Gisele Cardoso de Amorim; Tallita Eduarda da Veiga; Jesiel Cardoso; Alberto Cardoso Arruda; Mara Silvia Pinheiro Arruda; Morgana T L Castelo-Branco
Journal: J Biol Inorg Chem Date: 2019-04-27 Impact factor: 3.358

4. Combined therapy with cisplatin and 5-AZA-2CdR modifies methylation and expression of DNA repair genes in oral squamous cell carcinoma.

Authors: Dieila Giomo Lima; Guilherme Castro Lima Silva do Amaral; Aline Cristiane Planello; Gabriell Bonifacio Borgato; Gustavo Narvaes Guimarães; Ana Paula de Souza
Journal: Int J Clin Exp Pathol Date: 2022-03-15

Review 5. Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management.

Authors: Mohammad Aslam Khan; Kunwar Somesh Vikramdeo; Sarabjeet Kour Sudan; Seema Singh; Annelise Wilhite; Santanu Dasgupta; Rodney Paul Rocconi; Ajay Pratap Singh
Journal: Semin Cancer Biol Date: 2021-08-18 Impact factor: 15.707

Review 6. Recent Advances in Electrochemotherapy.

Authors: Maja Cemazar; Gregor Sersa
Journal: Bioelectricity Date: 2019-12-12

7. Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.

Authors: Tamara Mirzapoiazova; Gang Xiao; Bolot Mambetsariev; Mohd W Nasser; Emily Miaou; Sharad S Singhal; Saumya Srivastava; Isa Mambetsariev; Michael S Nelson; Arin Nam; Amita Behal; Leonidas Arvanitis; Pranita Atri; Markus Muschen; François L H Tissot; James Miser; John S Kovach; Martin Sattler; Surinder K Batra; Prakash Kulkarni; Ravi Salgia
Journal: Mol Cancer Ther Date: 2021-07-12 Impact factor: 6.261